<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>07640187920390</udiDi>
    <basicUdiDi>B-07640187920390</basicUdiDi>
    <tradeName>Aliaxin SR - Shape &amp; Restore (Standard)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin SR - Shape &amp; Restore (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T17:51:51.490Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920598</udiDi>
    <basicUdiDi>B-07640187920598</basicUdiDi>
    <tradeName>LMW-CL-HA FACE/BODY</tradeName>
    <deviceName>LMW-CL-HA FACE/BODY</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LMW-CL-HA FACE/BODY</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:43.825Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920581</udiDi>
    <basicUdiDi>B-07640187920581</basicUdiDi>
    <tradeName>LMW-CL-HA Arthro</tradeName>
    <deviceName>LMW-CL-HA ARTHRO</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>LMW-CL-HA Arthro</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:43.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920574</udiDi>
    <basicUdiDi>B-07640187920574</basicUdiDi>
    <tradeName>Aliaxin SV - Superior Volume (Ukraine)</tradeName>
    <deviceName>ALIAXIN/NUAVIS</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Aliaxin SV - Superior Volume (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:42.234Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920567</udiDi>
    <basicUdiDi>B-07640187920567</basicUdiDi>
    <tradeName>Aliaxin SV - Superior Volume (Direct Countries)</tradeName>
    <deviceName>ALIAXIN/NUAVIS</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin SV - Superior Volume (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:41.560Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920550</udiDi>
    <basicUdiDi>B-07640187920550</basicUdiDi>
    <tradeName>Aliaxin SV - Superior Volume (Standard)</tradeName>
    <deviceName>ALIAXIN/NUAVIS</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin SV - Superior Volume (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:36.618Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920543</udiDi>
    <basicUdiDi>B-07640187920543</basicUdiDi>
    <tradeName>Viscoderm Hydrobooster (Ukraine)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Viscoderm Hydrobooster (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:35.024Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920536</udiDi>
    <basicUdiDi>B-07640187920536</basicUdiDi>
    <tradeName>Viscoderm Hydrobooster (Direct Countries)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Viscoderm Hydrobooster (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:34.216Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920529</udiDi>
    <basicUdiDi>B-07640187920529</basicUdiDi>
    <tradeName>Viscoderm Hydrobooster (Standard)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Viscoderm Hydrobooster (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:33.420Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920512</udiDi>
    <basicUdiDi>B-07640187920512</basicUdiDi>
    <tradeName>Aliaxin LV - Lips Volume (Ukraine)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Aliaxin LV - Lips Volume (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:29.422Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920505</udiDi>
    <basicUdiDi>B-07640187920505</basicUdiDi>
    <tradeName>Aliaxin Ev - Essential Volume (Ukraine)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Aliaxin Ev - Essential Volume (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:28.622Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920499</udiDi>
    <basicUdiDi>B-07640187920499</basicUdiDi>
    <tradeName>Aliaxin SR - Shape &amp; Restore (Ukraine)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Aliaxin SR - Shape &amp; Restore (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:27.816Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920482</udiDi>
    <basicUdiDi>B-07640187920482</basicUdiDi>
    <tradeName>Aliaxin FL - Lips (Ukraine)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Aliaxin FL - Lips (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:27.039Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920475</udiDi>
    <basicUdiDi>B-07640187920475</basicUdiDi>
    <tradeName>Aliaxin GP - Global Performance (Ukraine)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Aliaxin GP - Global Performance (Ukraine)</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:23.016Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920468</udiDi>
    <basicUdiDi>B-07640187920468</basicUdiDi>
    <tradeName>Aliaxin LV - Lips Volume (Direct Countries)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin LV - Lips Volume (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:22.215Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920451</udiDi>
    <basicUdiDi>B-07640187920451</basicUdiDi>
    <tradeName>Aliaxin EV - Essential Volume (Direct Countries)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin EV - Essential Volume (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:21.421Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920444</udiDi>
    <basicUdiDi>B-07640187920444</basicUdiDi>
    <tradeName>Aliaxin SR - Shape &amp; Restore (Direct Countries)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin SR - Shape &amp; Restore (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:20.618Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920437</udiDi>
    <basicUdiDi>B-07640187920437</basicUdiDi>
    <tradeName>Aliaxin FL - Lips (Direct Countries)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin FL - Lips (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:15.798Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920420</udiDi>
    <basicUdiDi>B-07640187920420</basicUdiDi>
    <tradeName>Aliaxin GP - Global Performance (Direct Countries)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin GP - Global Performance (Direct Countries)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:15.013Z</lastUpdated>
  </row>
  <row>
    <udiDi>07640187920413</udiDi>
    <basicUdiDi>B-07640187920413</basicUdiDi>
    <tradeName>Aliaxin LV - Lips Volume (Standard)</tradeName>
    <deviceName>INTRADERMAL CROSS-LINKED HA</deviceName>
    <manufacturerName>ROSE PHARMA S.A.</manufacturerName>
    <manufacturerSrn>CH-MF-000033472</manufacturerSrn>
    <authorisedRepresentativeName>ROSE PHARMA ITALIA S.R.L.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>IT-AR-000021266</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>Aliaxin LV - Lips Volume (Standard)</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-09-21T16:30:14.230Z</lastUpdated>
  </row>
</eudamedExport>